Preclinical evaluation of lovastatin
- 11 November 1988
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (15), J16-J27
- https://doi.org/10.1016/0002-9149(88)90003-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- Discovery, biochemistry and biology of lovastatinThe American Journal of Cardiology, 1988
- 3-Hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors: A New Class of Cholesterol-Lowering AgentsAnnals of Internal Medicine, 1987
- The genotoxic/epigenetic distinction: Relevance to cancer policyEnvironmental Research, 1984
- Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductaseTeratology, 1983
- An Analysis of the Carcinogenesis Testing Experience of the National Cancer InstituteToxicologic Pathology, 1982
- Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animalsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
- ANTICONVULSANT DRUGS AND CANCER A Cohort Study in Patients with Severe EpilepsyThe Lancet, 1979
- Lack of correlation between the rate of cholesterol biosynthesis and the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rats and in fibroblasts treated with ML-236BBiochemical and Biophysical Research Communications, 1978
- Biochemistry of Polyisoprenoid BiosynthesisAnnual Review of Biochemistry, 1976